BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10127574)

  • 1. Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels.
    Golightly LK; O'Fallon CL; Moran WD; Sorocki AH
    Hosp Pharm; 1993 Aug; 28(8):725-7, 730-2. PubMed ID: 10127574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-based program for identifying medication orders requiring dosage modification based on renal function.
    Goldberg DE; Baardsgaard G; Johnson MT; Jolowsky CM; Shepherd M; Peterson CD
    Am J Hosp Pharm; 1991 Sep; 48(9):1965-9. PubMed ID: 1928142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs.
    Peterson JP; Colucci VJ; Schiff SE
    Am J Hosp Pharm; 1991 Sep; 48(9):1962-4. PubMed ID: 1928141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Care plan for documenting pharmacist activities.
    Chase PA; Bainbridge J
    Am J Hosp Pharm; 1993 Sep; 50(9):1885-8. PubMed ID: 8135234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist as team leader for total parenteral nutrition therapy.
    Greenlaw CW
    Am J Hosp Pharm; 1979 May; 36(5):648-50. PubMed ID: 110145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of clinical pharmacist interventions in a hemodialysis unit.
    Tang I; Vrahnos D; Hatoum H; Lau A
    Clin Ther; 1993; 15(2):459-64; discussion 432. PubMed ID: 8519051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist involvement in a thyroid clinic.
    Dong BJ
    Am J Hosp Pharm; 1990 Feb; 47(2):356-61. PubMed ID: 2309725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug prescribing for patients with changing renal function.
    CantĂș TG; Ellerbeck EF; Yun SW; Castine SD; Kornhauser DM
    Am J Hosp Pharm; 1992 Dec; 49(12):2944-8. PubMed ID: 1481798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-based antimicrobial-monitoring service.
    Berman JR; Zaran FK; Rybak MJ
    Am J Hosp Pharm; 1992 Jul; 49(7):1701-6. PubMed ID: 1621727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication reconciliation in a rural trauma population.
    Miller SL; Miller S; Balon J; Helling TS
    Ann Emerg Med; 2008 Nov; 52(5):483-91. PubMed ID: 18550221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist assessment of drug allergies.
    Tripp DM; Brown GR
    Am J Hosp Pharm; 1993 Jan; 50(1):95-8. PubMed ID: 8427287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent pharmacist monitoring of gentamicin therapy.
    Powell SH; Lantos RL
    Am J Hosp Pharm; 1981 Jan; 38(1):77-8. PubMed ID: 7211874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a clinical pharmacokinetic service for gentamicin in a community hospital.
    Wallace SM; Gesy K; Gorecki DK
    Can J Hosp Pharm; 1984; 37(1):10-4. PubMed ID: 10265730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-use evaluation programs for psychotropic medications.
    Goad JD; Ezell JR
    Am J Hosp Pharm; 1990 Jan; 47(1):132-6. PubMed ID: 2301421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676].
    Makowsky MJ; Koshman SL; Midodzi WK; Tsuyuki RT
    Med Care; 2009 Jun; 47(6):642-50. PubMed ID: 19433997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.